Skip to content

Clinical trials

Myasthenia Gravis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: France Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20131
20142
20152
20171
20181
20196
20202
20217
20222
202412
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting14
Active, not recruiting11
Enrolling by invitation2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx8
Centre Hospitalier Universitaire de Nice5
Alexion Pharmaceuticals, Inc.4
Assistance Publique - Hôpitaux de Paris4
UCB Biopharma SRL4
Novartis Pharmaceuticals3
Amgen2
Fondation Ophtalmologique Adolphe de Rothschild2
Grifols Therapeutics LLC2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis51
Atypical Hemolytic Uremic Syndrome1
COVID-191
Dyspnea1
Fatigue1
Guillain-Barre Syndrome1
Hemoglobinuria, Paroxysmal1
Lambert-Eaton Myasthenic Syndrome1
Multiple Sclerosis1
Myasthenic Syndromes, Congenital1

Trials

Showing 26 to 50 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.